TD Cowen lowered the firm’s price target on Standard BioTools (LAB) to $2.50 from $2.75 and keeps a Buy rating on the shares. The firm said they reported a 9% sales beat with margins ahead and cost controls solid, though sales upside was largely timing-related.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LAB: